Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 21, 2015; 21(35): 10234-10241
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10234
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10234
Table 1 Demographic and clinical data at baseline (intention-to-treat population) n (%)
MBST | Hybrid | P value | |
Included in ITT analysis | 140 | 144 | - |
Age, mean ± SD (yr) | 58.9 ± 12.8 | 58.8 ± 11.9 | 0.922 |
Gender (male) | 58 (41.4) | 72 (50.0) | 0.155 |
Current smoker | 8 (5.7) | 9 (6.3) | 0.849 |
Alcohol drinking | 18 (12.9) | 15 (10.4) | 0.581 |
Diabetes | 7 (5.0) | 6 (4.2) | 0.783 |
Hypertension | 27 (19.3) | 20 (13.9) | 0.264 |
Previous history of peptic ulcer | 19 (13.6) | 18 (12.5) | 0.537 |
Endoscopic diagnosis | 0.783 | ||
HPAG | 117 (83.6) | 136 (94.4) | |
Gastric ulcer | 8 (5.7) | 6 (4.2) | |
Duodenal ulcer | 5 (3.6) | 0 (0.0) | |
Gastric and duodenal ulcer | 2 (1.4) | 2 (1.4) | |
Adenoma | 8 (5.7) | 0 (0.0) | |
Positive CLO test | 106 (75.7) | 116 (80.6) | 0.389 |
H. pylori colonization | 0.234 | ||
Negative | 7 (5.0) | 13 (9.0) | |
Mild | 66 (47.1) | 65 (45.1) | |
Moderate | 52 (37.1) | 43 (29.9) | |
Marked | 15 (10.7) | 23 (16.0) | |
Atrophic change | 11 (7.8) | 14 (9.8) | 0.122 |
Intestinal metaplasia | 10 (7.2) | 16 (11.1) | 0.239 |
Drop out | 4 (2.8) | 6 (4.1) | 0.285 |
Noncompliance | 0 (0.0) | 0 (0.0) | |
Follow-up loss | 4 (2.8) | 6 (4.1) | |
Discontinued therapy | 0 (0.0) | 0 (0.0) | |
due to adverse events |
-
Citation: Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line
Helicobacter pylori eradication. World J Gastroenterol 2015; 21(35): 10234-10241 - URL: https://www.wjgnet.com/1007-9327/full/v21/i35/10234.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i35.10234